The management of depression. The place of the new antidepressants. Part 1. General overview.
The introduction of the selective serotonin reuptake inhibitors, moclobemide and mianserin has been a major advance in the treatment of depression, and is already leading to major shifts in the pattern of antidepressants prescribing. These antidepressants are safe, well tolerated and effective, and in conjunction with older agents such as the tricyclics, provide the clinician with a broad range of treatments for this common and disabling disorder. This two-part review will focus on the management of depression in general practice.
Mitchell
P B
PB
School of Psychiatry, University of New South Wales.
Mitchell
M S
MS
D000465:Algorithms; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003863:Depression / Q000175:diagnosis / Q000628:therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D011613:Psychotherapy; D016896:Treatment Outcome
D000928:Antidepressive Agents